AMBALAL SARABHAI share price has zoomed 5% and is presently trading at Rs 64.4.
Meanwhile, the BSE HEALTHCARE index is at 38,306.2 (down 0.4%).
Among the top gainers in the BSE HEALTHCARE index today are Pfizer (up 4.1%) and KIMS (up 2.1%).
ALKEM LABORATORIES (down 2.4%) and HIKAL CHEMIC (down 2.0%) are among the top losers today.
Over the last one year, AMBALAL SARABHAI has moved up from Rs 27.2 to Rs 64.4, registering a gain of Rs 37.1 (up 136.4%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,306.2, registering a gain of 47.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 101.7%), Lupin (up 99.8%) and Cadila Healthcare (up 99.6%).
Dear Reader: If You Invest in Midcap Stocks, this is for You
The BSE Sensex is at 79,695.6 (down 0.8%).
The top losers among the BSE Sensex today are M&M (down 7.5%) and HCl Tech. (down 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,275.0 (down 0.7%). M&M and HCl Tech. are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,695.6, registering a gain of 14,351.4 points (up 22.0%).
AMBALAL SARABHAI net profit grew 131.5% YoY to Rs 101 million for the quarter ended March 2024, compared to a profit of Rs 44 million a year ago. Net sales rose 22.3% to Rs 543 million during the period as against Rs 444 million in January-March 2023.
For the year ended March 2024, AMBALAL SARABHAI reported 50.4% decrease in net profit to Rs 57 million compared to net profit of Rs 114 million during FY23. Revenue of the company grew 1.9% to Rs 1,736 million during FY24.
The current Price to earnings ratio of AMBALAL SARABHAI, based on rolling 12 month earnings, stands at 58.8.
Equitymaster requests your view! Post a comment on "AMBALAL SARABHAI Gains 5%; BSE HEALTHCARE Index Down 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!